BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25739639)

  • 1. (18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.
    Yokobori Y; Toyoda M; Sakakura K; Kaira K; Tsushima Y; Chikamatsu K
    Acta Otolaryngol; 2015 May; 135(5):494-9. PubMed ID: 25739639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma.
    Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim MS
    Int J Oral Maxillofac Surg; 2013 Feb; 42(2):158-63. PubMed ID: 23219708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas.
    Suzuki H; Fukuyama R; Hasegawa Y; Tamaki T; Nishio M; Nakashima T; Tatematsu M
    Oral Oncol; 2009 Oct; 45(10):891-7. PubMed ID: 19457711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.
    Han MW; Lee HJ; Cho KJ; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Head Neck; 2012 Oct; 34(10):1395-402. PubMed ID: 22052623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; See LC; Yen TC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):764-71. PubMed ID: 18835509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.
    Miyashita G; Higuchi T; Oriuchi N; Arisaka Y; Hanaoka H; Tominaga H; Morita S; Miyakubo M; Ishikita T; Nakasone Y; Negishi A; Yokoo S; Endo K
    Ann Nucl Med; 2010 Oct; 24(8):579-84. PubMed ID: 20652456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of 18F-fluorodeoxyglucose-positron emission tomography uptake as a prognostic factor for paranasal sinus malignancy.
    Seol JH; Kim J; Lee JD; Lee JG; Yoon JH; Kim CH
    Am J Rhinol Allergy; 2013; 27(2):118-22. PubMed ID: 23562200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma.
    Suzuki H; Hasegawa Y; Terada A; Hyodo I; Nakashima T; Nishio M; Tamaki T
    Oral Oncol; 2009 Jul; 45(7):569-73. PubMed ID: 18804407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
    Nobusawa A; Kim M; Kaira K; Miyashita G; Negishi A; Oriuchi N; Higuchi T; Tsushima Y; Kanai Y; Yokoo S; Oyama T
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1692-700. PubMed ID: 23801167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
    World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
    Kita Y; Okumura H; Uchikado Y; Sasaki K; Omoto I; Matsumoto M; Setoyama T; Tanoue K; Mori S; Owaki T; Ishigami S; Ueno S; Kajiya Y; Natsugoe S
    Ann Surg Oncol; 2013 May; 20(5):1646-52. PubMed ID: 23238695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.
    Chung MK; Jeong HS; Son YI; So YK; Park GY; Choi JY; Hyun SH; Kim HJ; Ko YH; Baek CH
    Ann Surg Oncol; 2009 Nov; 16(11):3111-7. PubMed ID: 19609618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
    Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography helpful in the decision-making process for neck dissection in patients with T1-T2 lingual cancer?
    Shinohara S; Kikuchi M; Suehiro A; Kishimoto I; Harada H
    Acta Otolaryngol; 2015 Feb; 135(2):181-6. PubMed ID: 25539188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the maximum standardized uptake value of fluoro-2-deoxyglucose-positron emission tomography/computed tomography and clinicopathological characteristics in tongue squamous cell carcinoma.
    Zheng D; Niu L; Liu W; Zheng C; Yan R; Gong L; Dong Z; Fei J; Li K
    J Cancer Res Ther; 2019; 15(4):842-848. PubMed ID: 31436241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
    Schreurs LM; Smit JK; Pavlov K; Pultrum BB; Pruim J; Groen H; Hollema H; Plukker JT
    Ann Surg Oncol; 2014 Nov; 21(12):3751-7. PubMed ID: 24939624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.